Another honour for senior SAHMRI researcher

SAHMRI’s Precision Cancer Medicine Co-Leader, Professor Tim Hughes, has been recognised for his outstanding contribution to science by being elected as a Fellow of the Australian Academy of Science.

Prof Hughes has made key contributions towards the development and refinement of kinase inhibitor therapy for cancer, through his pioneering work in chronic myeloid leukaemia (CML). 

He was a leader on many of the key clinical trials that underpinned the transformation of CML from a fatal disease to a treatable chronic condition.

Prof Hughes demonstrated and championed the key role of molecular monitoring to optimise response in CML and pioneered the concept of treatment-free remission as a pathway to cure in CML. This has heralded an exciting new era in cancer therapy where molecularly-defined targets are identified and specifically inhibited.